Tuesday, May 20, 2014 9:30:41 AM
ROTH Specifics:
Product: Sucanon is quite "internet friendly". There is a ton of information and links, and it can be researched very easily.
Is it marketable? With a target market of Type II diabetes, (again, easily researched), it appears to have a broad and growing market, AND since it is not a "once and done" medication, if it shows positive results, it is a repeat seller.
People: Always have to start with CEOs, which in this case would be Luis Lopez. I haven't had much time to do a thorough background of him, so I cannot comment at this time. Also, I have a criteria of knowing what his relationship is to shareholders. Also to be investigated at a future time.
There was an announcement recently of some doctors added to the advisory board. Need to investigate them as well, not only for educational/experience background, but business savvy as well.
Processes: Still early in my DD, but it appears that several major steps have been taken to facilitate production and sales of their product, namely PNP Pharm. as manufacturer and MDR/Nadro as distributors in Mexico. (Still investigating those companies and their potentials).
Also, there has been movement under the FDA, which indicates a movement forward and a desire to expand the market, potentially in US and other countries.
Some of the other ingredients we have to mix in as investors, would include share structure/share responsibility, reporting, communications, and future growth/potential.
I could ramble on and on about specifics or details of what I look at, but to no good end. Hoping this gives you a frame of reference for what I do in my DD, and maybe it will help you with yours.
Best.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM